Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecast-2028

Albany, NY -- (SBWire) -- 07/01/2019 --Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecast-2028

1 July 2018

1. Prader-Willi Syndrome occurs in approximately one out of every 15,000 births.
2. Prader Willi syndrome total prevalent cases were found to be 47,000 for 7 Major Markets in the year 2017.
3. Prader-Willi Syndrome incidence is between 1 in 10,000-30,000 individuals.

(Albany, US) DelveInsight launched a new report on Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Prader-Willi Syndrome market report covers a descriptive overview and comprehensive insight of the Prader-Willi Syndrome epidemiology and Prader-Willi Syndrome market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Prader-Willi Syndrome market report provides insights on the current and emerging therapies.
3. Prader-Willi Syndrome market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Prader-Willi Syndrome market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Prader-Willi Syndrome market.

Request for sample pages

"Prader-Willi Syndrome affects males and females with equal frequency and affects all races and ethnicities."

Prader-Willi Syndrome treatment is currently based on treating Prader-Willi Syndrome symptoms. Growth hormone deficiency is present in almost all children and many adults with Prader-Willi Syndrome. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome. HGH is effective not only in increasing height, but also in decreasing body fat, increasing muscle mass, improving weight distribution, increasing stamina, and increasing bone mineral density.

The global Prader-Willi Syndrome market is accounted for by symptomatic therapies used for treating the co-morbidities such as diabetes, obesity, cardiovascular disorders, etc. associated with Prader-Willi Syndrome. Rising awareness and improvement in Prader-Willi Syndrome diagnosis shall serve as vital Prader-Willi Syndrome market drivers.

Prader-Willi Syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world and expected the launch of Prader-Willi Syndrome emerging therapies during the forecast period of 2019-2028. Companies across the globe are working towards the development of new Prader-Willi Syndrome treatment therapies and have also been a part of the Prader-Willi Syndrome Clinical Trial Consortium.

Due to the rarity of the indication, some of the companies have recently shifted their focus towards this indication, yet others are expected to create a significant influence on Prader-Willi Syndrome market size during the forecast period.

Key players such as
1. Millendo Therapeutics
2. INSYS Therapeutics
3. Soleno Therapeutics
4. Novo-Nordisk
5. Consynance
6. Saniona

and many others are involved in developing Prader-Willi Syndrome therapies like
1. Livoletide or AZP-531
2. Cannabidoil
3. Diazoxide Controlled Release
4. CSTI-100
5. CSTI-500

Table of contents

1. Key Insights
2. Prader-Willi Syndrome Market Overview at a Glance
3. Prader-Willi syndrome Disease Background and Overview
4. Prader-Willi Syndrome Epidemiology and Patient Population
5. Prader-Willi Syndrome Country Wise-Epidemiology
6. United States
7. EU-5
8. Germany
9. France
10. Italy
11. Spain
12. United Kingdom
13. Japan
14. Prader-Willi Syndrome Treatment
15. Prader-Willi Syndrome Unmet Needs
16. Prader-Willi Syndrome Marketed Drugs
16.1. GENOTROPIN: Pfizer
16.2. Other Hormonal Therapies
17. Prader-Willi Syndrome Emerging Drugs Analysis
18. Prader-Willi Syndrome Emerging Therapies
18.1. Livoletide: Millendo Therapeutics
18.2. LV-101: Levo Therapeutics
18.3. Liraglutide: Novo Nordisk
19. Prader-Willi Syndrome 7 Major Market Analysis
20. Prader-Willi Syndrome Market Outlook by Country
20.1. The United States: Market Outlook
20.2. United States Market Size
20.3. EU-5 Countries: Market Outlook
20.4. Germany Market Size
20.5. France Market Size
20.6. Italy Market Size
20.7. Spain Market Size
20.8. The United Kingdom Market Size
20.9. Japan: Market Outlook
20.10. Japan: Market Size
21. Market Drivers
22. Market Barriers
23. Appendix
24. Prader-Willi Syndrome Report Methodology
25. DelveInsight Capabilities
26. Disclaimer
27. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight